(September 1994 - May 1998) 

(Listed by article name, date of publication, and page, with oldest article first)

The RU 486 Report is a monthly newsletter focusing on abortion drugs, with special emphasis on RU 486. SUBSCRIPTION INFORMATION: Twelve issues per year for $25.00. Send name, mailing address, and check to Life Issues Institute, 1721 W. Galbraith Rd., Cincinnati, OH 45239. Phone: (513) 729-3600, FAX (513) 729-3636.

Cytotec (misoprostol)

Misused with RU 486, Jan. 1995, p. 1.

"Citizen Petition" side effects, Feb./Mar. 1995, p. 3-4.

Misused for 2nd Trimester Abortion, Feb./Mar. 1995, p. 6.

Used with methotrexate (MTX), see "methotrexate" listing.

Methotrexate (MTX) and Cytotec (misoprostol) Prostaglandin Abortion Method

Poses Threat, Apr. 1995, pp. 1-4.

More Tests Begin, May 1995, p. 2-4.

Study Ignores Dangers, Nov. 1995, pp. 2-4.

Researcher Opposes Abortion Use, Dec. 1995 p. 1.

Not "Standard of Care," Dec. 1995, p. 2.

Two Chemical Abortion Methods May Be On U.S. Market Soon, Apr. 1996, p. 1.

FACT SHEET, Comparison of Chemical Abortion Methods: RU 486/Prostaglandin and Methotrexate (MTX)/ Prostaglandin, Oct. 1996, p. 2.

Planned Parenthood Starts Nationwide Methotrexate/Prostaglandin Abortion Test, Oct. 1996, p. 3.

Methotrexate/Cytotec Prostaglandin Abortion: An Annotated Chronology and Bibliography, Jan.-Feb. 1998, p. 5.

RU 486 (mifepristone) Boycott

Status, Sept. 1994, p. 2.

Gathers Steam, Feb./Mar. 1995, p. 5.

New Boycott Target, June 1995, p. 1.

21 National Groups Declare Renewed RU 486 Consumer Boycott, Mar. 1996, p. 1.

RU 486: Where Do We Go From Here?, Sept. 1996, p. 1.

Renewed Boycott Pressure on Hoechst Needed, Dec. 1996-Jan. 1997, p. 1.

Hoechst "Donates" European RU 486 Patent to Avoid Consumer Boycott, Apr. 1997, p. 1.

RU 486 Public Debate / Action Items

What You Can Do, Nov. 1994, p. 4

RU 486 as "Medicine," Nov. 1994, p. 3.

"Citizen Petition" Follow up, Feb./Mar. 1995, p. 4.

Soundbites, Feb./Mar. 1995, p. 6.

Sample Speech Against RU 486, Aug. 1995, p. 1.

Safety Concerns at Center of Debate, Sept. 1995, p. 1.

What Is Happening With RU 486? Questions, Answers, and Theories, Feb. 1996, p. 1.

Two Chemical Abortion Methods May Be On U.S. Market Soon, Apr. 1996, p. 1.

Local Opposition Vital To Prevent More Doctors From Performing RU 486 Abortions, May 1996, p. 1.

Assessing the "Acceptability" of Chemical Abortion Methods, June 1996, p. 1.

Quick Response to Media On Upcoming RU 486 Publication Essential, July 1996, p. 1.

FDA Advisory Committee Recommends RU 486 Approval, Aug. 1996, p. 1.

RU 486: Where Do We Go From Here?, Sept. 1996, p. 1.

RU 486 "Approvable" for U.S. Market by mid-1997, Oct. 1996, p. 1.

FACT SHEET, Comparison of Chemical Abortion Methods: RU 486/Prostaglandin and Methotrexate (MTX)/ Prostaglandin, Oct. 1996, p. 2.

Hoechst "Donates" European RU 486 Patent to Avoid Consumer Boycott, Apr. 1997, p. 1.

Great Opportunity to Refute Myths about the Non-Abortion Uses of RU 486, Sept.-Oct. 1997, p. 1.

RU 486 Proponents / Food and Drug Administration (FDA)

Goal of Adding Abortionists, Nov. 1994, p. 1.

"Citizen Petition" Given to FDA, Feb./Mar. 1995, pp. 1-2.

FDA Wary of Citizen Petition, May 1995, p. 1.

Key Post to RU 486 Advocate, May 1995, p. 4.

Objective Evaluation Impossible for FDA, Oct. 1995, p. 1.

What Is Happening With RU 486? Questions, Answers, and Theories, Feb. 1996, p. 1.

Federal Research Underway on New Abortion Drug, Feb. 1996, p. 3.

RU 486 Hits Roadblock In Australia, July 1996, p. 4.

FDA Advisory Committee Recommends RU 486 Approval, Aug. 1996, p. 1.

RU 486 "Approvable" for U.S. Market by mid-1997, Oct. 1996, p. 1.

Details Emerge About "Stealth" Abortion-Pill Company, Nov. 1996, p. 1.

Lawsuits May Delay RU 486 Debut, Dec. 1996-Jan. 1997, p. 2.

With Key RU 486 Lawsuit Settled, Proponents Aim for U.S. Sales by Year’s End, Feb.-Mar. 1997, p. 1.

Hoechst "Donates" European RU 486 Patent to Avoid Consumer Boycott, Apr. 1997, p. 1.

New Contract Dispute Delays U.S. RU 486 Marketing, July 1997, p. 1.

Status of Chemical Abortion Drugs Under Development in the U.S., Aug. 1997, p. 2.

Lawsuits Partially Settled, But Obstacles Remain to RU 486 Sales in U.S., Nov.-Dec. 1997, p. 1.

Key RU 486 Marketing Effort Stalled, But Research Continues," Jan.-Feb. 1998, p. 1.

RU 486 Side Effects / Dangers

Dangerous Fallout, Nov. 1994, p. 2.

"Citizen Petition" filed, Feb./Mar. 1995, pp. 1-4.

Not As Easy As Promised, Part I, July 1995, p. 1.

List of side effects and dangers in sample speech, Aug. 1995, pp. 3-4.

Safety Concerns at Center of Debate, Sept. 1995, p. 1.

Not As Easy As Promised, Part II, Oct. 1995, p. 4.

Safety and Efficacy Questions, Nov. 1995, p. 1.

Not As Easy As Promised , Part III, Dec.1995, p. 4.

RU 486 "Near-Death" Accident in Iowa Raises Safety Questions, Jan. 1996, p. 1.

Assessing the "Acceptability" of Chemical Abortion Methods, June 1996, p. 1.

FDA Advisory Committee Recommends RU 486 Approval, Aug. 1996, p. 1.

FACT SHEET, Comparison of Chemical Abortion Methods: RU 486/Prostaglandin and Methotrexate (MTX)/ Prostaglandin, Oct. 1996, p. 2.

New Insights from Abortion-Pill Test, Aug. 1997, p. 1.

The Facts Against RU 486 Abortion: An Update, Mar.-Apr. 1998

Article on U.S. RU 486 Test Gives More Details About Dangers to Women, May 1998.

RU 486 Testing

No News, Good News, Sept. 1994, p. 1.

No NY State Funding, Sept. 1994, p. 2.

Australian Tests Suspended, Sept. 1994, p. 3.

Status of tests (table), Sept. 1994, p. 4.

Tests Begin, Nov. 1994, p. 1.

Trial Starts in St. Louis, May 1995, p. 1.

12th Test Site Announced, July 1995, p. 4.

Trials End, Nov. 1995, p. 1.

Two Chemical Abortion Methods May Be On U.S. Market Soon, Apr. 1996, p. 1.

Assessing the "Acceptability" of Chemical Abortion Methods, June 1996, p. 1.

RU 486 Hits Roadblock In Australia, July 1996, p. 4.

Canadian Official Rejects Fast-Track Approval for RU 486 Abortion, May 1997, p. 1.

U.S. Testing of "Chinese" RU 486 "Clone," July 1997, p. 3.

New Insights from Abortion-Pill Test, Aug. 1997, p. 1.

Status of Chemical Abortion Drugs Under Development in the U.S., Aug. 1997, p. 2.

Key RU 486 Marketing Effort Stalled, But Research Continues," Jan.-Feb. 1998, p. 1.